INOVIO PHARMACEUTICALS, INC. for INOVIO PHARMACEUTICALS, INC.
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to Recurrent Respiratory Papillomatosis (RRP), an HPV associated disease; Issues related to the Orphan Drug Act and orphan drug destination; Issues related to the Orphan Drug Tax Credit; Issues related to Accelerated Approval reforms and accelerated approval pathway at FDA and decentralized trials; Issues related to CMS IRA implementation and small biotech exemption; Issues related to the Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization; Next Generation COVID-19 vaccines and boosters; Issues related to ASPR/BARDA and manufacturing of pan-coronavirus vaccines and boosters; Issues related to Oncology and HPV cancers and other associated diseases; Issues related to medical devices and cybersecurity issues; Issues related to Transitional Coverages of Emerging Technologies (TCET) and medical devices; Issues related to FY2024 Labor, Health and Human Services and Education Annual Appropriations; DNA Medicines Platform Technology awareness
| Lobbyist | Covered position, as disclosed |
|---|---|
| COOKAB HASHEMI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.